Literature DB >> 27803775

Plexiform angiomyxoid myofibroblastic tumor of stomach: A rare case.

Laimas Jonaitis1, Mindaugas Kiudelis1, Paulius Slepavicius1, Lina Poskienė1, Limas Kupcinskas1.   

Abstract

Plexiform angiomyxoid myofibroblastic tumor (PAMT) is a rare benign mesenchymal tumor of stomach. Rarity of this kind of tumors and scarce review articles may cause underrecognition of this entity and pose a real diagnostic challenge to gastroenterologists, pathologists and surgeons when encountering such patients and differentiating PAMT from other gastric intramural tumors. We report a case of 28-year-old woman, who presented with epigastric pain after meals, iron-deficiency anaemia and weight loss. Upper gastrointestinal endoscopy revealed submucosal tumor-like elevated lesion in the anterior wall of the antrum with intact overlying mucosa. Endoscopic ultrasound showed a 3-cm hypoechoic homogenous mass, originating from the third layer of the gastric wall. Endoscopic ultrasound-guided fine needle aspiration was not informative. Endoscopic buttonhole biopsy was performed to obtain specimens. Following this, the unexpected prolapse of the tumor occurred into the lumen of the stomach, causing gastric outlet obstruction - the biopsy was obtained. Pathomorphological features suggested the diagnosis of PAMT. Gastric resection of the Billroth I type was performed. Diagnosis was confirmed by histological analysis of the surgical specimen.

Entities:  

Keywords:  Antrum; Intramural; Mesenchymal; Plexiform angiomyxoid myofibroblastic tumor; Submucosal

Year:  2016        PMID: 27803775      PMCID: PMC5067475          DOI: 10.4253/wjge.v8.i18.674

Source DB:  PubMed          Journal:  World J Gastrointest Endosc


Core tip: Plexiform angiomyxoid myofibroblastic tumor is a rare benign mesenchymal tumor of stomach. Rarity of this kind of tumors and scarce review articles may cause underrecognition of this entity and pose a real diagnostic challenge, when differentiating between various intramural lesions. Clinical signs and symptoms are nonspecific or absent, radiological features often overlap, upper gastrointestinal endoscopy has a limited role because of intramural location. Endoscopic ultrasound yields opportunity to visualize and biopsy the tumor. Definite diagnosis requires histological and immunohistochemical analysis.

INTRODUCTION

Plexiform angiomyxoid myofibroblastic tumor (PAMT) is a benign mesenchymal tumor of stomach. To date, only 19 immunohistochemically confirmed cases have been reported in the literature. We report a case of 28-year-old woman with submucosal tumor in the anterior wall of the antrum. After repeated biopsies pathomorphological features of the specimen suggested the diagnosis of PAMT. Gastric resection of the Billroth I type was performed and diagnosis of PAMT was confirmed.

CASE REPORT

A 28-year-old previously healthy Caucasian female was ivestigated due to epigastric pain, associated with meals, iron-deficiency anaemia and lost 8 kg of weight during the preceding six months. Her previous medical history was unremarkable. Outpatient upper gastrointestinal endoscopy revealed submucosal tumor-like elevated lesion in the anterior wall of the antrum with intact overlying mucosa (Figure 1). Histology from that mucosa showed active chronic Helicobacter pylori-positive gastritis with reactive lymphoid hyperplasia.
Figure 1

Images from outpatient upper gastrointestinal endoscopy. Submucosal tumor with intact overlying mucosa is located in the anterior wall of the antrum. It partially obstructs the gastric outlet.

Images from outpatient upper gastrointestinal endoscopy. Submucosal tumor with intact overlying mucosa is located in the anterior wall of the antrum. It partially obstructs the gastric outlet. The endoscopic ultrasound was used to assess the tumor: It showed a 3-cm hypoechoic homogenous mass, originating from the third layer of the gastric wall. Endoscopic ultrasound-guided fine needle aspiration was performed to obtain specimens, but histopathological findings were not informative. Therefore endoscopic buttonhole biopsy was performed, but results were not informative again. After this procedure the patient was discharged home, but hospitalized again 7 d later due to vomiting, nausea and discomfort in the upper abdomen. The endoscopy revealed that submucosal mass protruded into the gastric lumen and caused gastric outlet obstruction (Figure 2). The biopsies were taken from protruded mass.
Figure 2

Endoscopic images from our case of plexiform angiomyxoid myofibroblastic tumor show multinodular tumor-like mass protruding into the gastric lumen after performed buttonhole biopsy. This mass blocks the pylorus resulting in the stasis of gastric content.

Endoscopic images from our case of plexiform angiomyxoid myofibroblastic tumor show multinodular tumor-like mass protruding into the gastric lumen after performed buttonhole biopsy. This mass blocks the pylorus resulting in the stasis of gastric content. This time microscopic features suggested the diagnosis of PAMT. The partial gastrectomy of the Billroth I type has been performed. Histological examination of resected tumor confirmed the diagnosis: Microscopically, gastric wall showed involvement of submucosa and muscularis propria by a tumor comprising plexiform islands of monomorphic spindle cells accompanied by abundant myxoid stroma, that was rich in small vessels. The surface of tumor was ulcerated with hyperplastic changes found in adjacent mucosa. On immunohistochemical staining, the tumor cells were positive for smooth muscle actin and negative for desmin, CD34 and S100 protein. Mitoses were rarely seen (< 1/50 HPF). The vascular endothelial Ki-67 labeling index was approximately 40% (Figure 3).
Figure 3

Multinodular plexiform growth pattern (A, B) and monomorphic spindle cells (C, D) accompanied by abundant myxoid stroma.

Multinodular plexiform growth pattern (A, B) and monomorphic spindle cells (C, D) accompanied by abundant myxoid stroma. Recovery after operation was complicated by gastroduodenal anastomositis, which was managed successfully with conservative measures. We plan to make the follow-up investigations (upper gastrointestinal endoscopy and abdominal ultrasound) for the possible recurrence of tumor after 6 mo and then once a year.

DISCUSSION

PAMT also known as plexiform fibromyxoma of stomach, is an unique benign mesenchymal gastric tumor, originating within the muscularis propria[1-6]. To date, only 19 immunohistochemically confirmed cases have been reported in the medical literature[7-9]. According to the reported cases of PAMT, the estimated frequency of this gastric mesenchymal tumor is less than 1/150 compared with that of gastric gastrointestinal stromal tumor (GIST). The patients’ ages range from 7 to 75 years (mean, 43 years) and approximate male-to-female ratio is 1:1[10-13]. The representative signs and symptoms include abdominal pain and discomfort, nausea, vomiting, and weight loss (caused by pyloric obstruction), hematemesis and anemia (associated with upper gastrointestinal bleeding caused by ulceration), palpable abdominal mass. Cystic degeneration, fistulating abscess formation and perforation were also reported[1,2,12]. Endoscopically, PAMT appears as submucosal mass, which ranges from 1.9 cm to 15 cm (mean, 6.3 cm)[14]. Tumor is always located in gastric antrum (there are presumptions about the possible origin from cells specifically distributed at this location of muscularis propria layer) though it can extend to the pylorus and duodenal bulb[15]. The overlying mucosa is often ulcerated. On computed tomography (CT) scan, the tumor appears relatively small (found in the gastric antrum). There is strong and heterogeneous internal enhancement effect. Small nodules show a strong enhancement effect in the rim[10]. The tumor also shows areas of low attenuation (because of the presence of myxoid tissue) and foci of vascularity. Magnetic resonance (MR) images demonstrate the myxoid stroma as T2-hyperintense lesion with persistent enhancement after administration of contrast material[3,5]. Histologically, PAMT is characterized by multinodular plexiform growth pattern (except for the extragastric tumor components). Tumor originates within the third layer of stomach wall - the muscularis propria - and may extend into the submucosa and mucosa, causing ulceration (furthermore, gastric content particles may impact into the fistulated tumor, resulting in abscess and pseudocyst formation). Bland-looking spindle tumor cells are separated by an abundant myxoid or fibromyxoid matrix, rich in capillaries. Nuclei of the tumor cells are oval or plump-shaped and cytoplasm is slightly eosinophilic. Nucleoli are small and inconspicious. Mitoses are rare (usually 0-4/50 HPF). The stroma is positive for Alcian blue stain, occasional collagenization may be observed. Immunohistochemical analysis of PAMT cells shows positivity for actin and vimentin, and negativity for CD34, S100P, KIT, DOG1, cytokeratin, neurofilament, epithelial membrane antigen, ALK. Tumor cells are mostly positive for α-smooth muscle actin (up to 80%), while positivity for desmin, CD10 and caldesmon is variable. Ki-67 usually demonstrates a very low proliferation index (1%-2%). Genetic studies show no mutations in KIT and PDGFRA[1,2,6,7,9,14]. Differential diagnoses of PAMT include GIST, which accounts for the majority of intramural gastric tumors, also inflammatory fibroid polyp, plexiform neurofibroma, myxoid leiomyoma, leiomyosarcoma, desmoid fibromatosis, gastric schwannoma, solitary fibrous tumor, inflammatory myofibroblastic tumor[4,8]. As mentioned before, differentiating between various intramural lesions may be difficult - clinical signs and symptoms are nonspecific or absent, radiological features often overlap, upper gastrointestinal endoscopy has a limited role because of intramural location. Endoscopic ultrasound yields opportunity to visualize and biopsy the tumor. Definite diagnosis requires histological and immunohistochemical analysis[11,16]. According to the described cases PAMT has good prognosis, no cases of local recurrence or metastasis had been reported. As gastric PAMT is so rare in clinical practice, special attention is necessary to recognise this entity and avoid misdiagnosis. Although absence of confirmed recurrences or metastases suggests that PAMT of stomach is benign[12], larger number of cases must be reported and analysed in order to specify it’s clinical significance, outcome and prognosis.

COMMENTS

Case characteristics

A 28-year-old previously healthy Caucasian female presented with epigastric pain, associated with meals, iron-deficiency anaemia and loss of weight during the preceding six months.

Clinical diagnosis

Submucosal tumor-like elevated lesion in the anterior wall of the antrum.

Differential diagnosis

Gastrointestinal stromal tumor, inflammatory fibroid polyp, plexiform neurofibroma, myxoid leiomyoma, leiomyosarcoma, desmoid fibromatosis, gastric schwannoma, solitary fibrous tumor, inflammatory myofibroblastic tumor.

Laboratory diagnosis

Iron-deficiency anaemia.

Imaging diagnosis

The endoscopic ultrasound showed a 3-cm hypoechoic homogenous mass, originating from the third layer of the gastric wall.

Pathological diagnosis

Plexiform angiomyxoid myofibroblastic tumor (PAMT).

Treatment

Partial gastrectomy of the Billroth I type.

Related reports

PAMT also known as plexiform fibromyxoma of stomach, is an unique benign mesenchymal gastric tumor, originating within the muscularis propria. To date, only 19 immunohistochemically confirmed cases have been reported in the medical literature.

Experiences and lessons

Differentiating between various intramural lesions may be difficult - clinical signs and symptoms are nonspecific or absent, radiological features often overlap, upper gastrointestinal endoscopy has a limited role because of intramural location. Definite diagnosis requires histological and immunohistochemical analysis.

Peer-review

The paper Plexiform angiomyxoid myofibroblastic tumor of stomach: A rare case is an interesting description of a rare condition of tumor. The case presented here shows that surgical intervention under is successful.
  15 in total

1.  [Plexiform fibromyxoma of stomach: a distinctive benign tumor of gastric antrum].

Authors:  Feng-hua Wang; Zheng-rong Chen; Hui-lin Niu; Rong-xin Zeng; Jian-qing Xia
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2012-03

Review 2.  Selected unusual tumors of the stomach: a review.

Authors:  Lai Mun Wang; Runjan Chetty
Journal:  Int J Surg Pathol       Date:  2011-11-30       Impact factor: 1.271

3.  [Plexiform angiomyxoid myofibroblastic tumour of the stomach].

Authors:  T Schulz; J Drgac; C Chmelar; T Höhler; A Agaimy; M Vieth
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

4.  Plexiform fibromyxoma (plexiform angiomyxoid myofibroblastic tumor) of stomach: an unusual presentation as a fistulating abscess.

Authors:  Peter W T Lee; Derek T W Yau; Patrick P L Lau; John K C Chan
Journal:  Int J Surg Pathol       Date:  2013-06-20       Impact factor: 1.271

Review 5.  Plexiform angiomyxoid myofibroblastic tumor of the stomach.

Authors:  Yoshihisa Takahashi; Masako Suzuki; Toshio Fukusato
Journal:  World J Gastroenterol       Date:  2010-06-21       Impact factor: 5.742

6.  Gastric plexiform angiomyxoid myofibroblastic tumor.

Authors:  Yetish Sing; Sumeshini Subrayan; Buhle Mqadi; Pratistadevi K Ramdial; Jenendhiran Reddy; Manogran S Moodley; Shamim Bux
Journal:  Pathol Int       Date:  2010-09       Impact factor: 2.534

7.  Presence of smooth muscle cell differentiation in plexiform angiomyxoid myofibroblastic tumor of the stomach: a case report.

Authors:  Peifeng Li; Shaolong Yang; Cuicui Wang; Yamin Li; Ming Geng
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

8.  A case of gastric plexiform fibromyxoma: radiological and pathological findings.

Authors:  Katsumi Sakamoto; Masakazu Hirakawa; Kazushige Atsumi; Koshi Mimori; Kohei Shibata; Taro Tobo; Hidetaka Yamamoto; Hiroshi Honda
Journal:  Jpn J Radiol       Date:  2014-04-18       Impact factor: 2.374

Review 9.  Beyond the GIST: mesenchymal tumors of the stomach.

Authors:  Hyunseon C Kang; Christine O Menias; Ayman H Gaballah; Stuti Shroff; Melissa W Taggart; Naveen Garg; Khaled M Elsayes
Journal:  Radiographics       Date:  2013-10       Impact factor: 5.333

10.  Plexiform fibromyxoma: a distinctive benign gastric antral neoplasm not to be confused with a myxoid GIST.

Authors:  Markku Miettinen; Hala R Makhlouf; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2009-11       Impact factor: 6.394

View more
  6 in total

1.  Computed tomography and magnetic resonance imaging of a plexiform angiomyxoid myofibroblastic tumor: a case report.

Authors:  Hiroyuki Akai; Shigeru Kiryu; Masaru Shinozaki; Yasunori Ohta; Yoshiyasu Nakano; Koichiro Yasaka; Kuni Ohtomo
Journal:  BMC Med Imaging       Date:  2017-01-19       Impact factor: 1.930

2.  Plexiform Fibromyxoma: A Rare Gastric Tumor.

Authors:  Casmir Wambura; Salim Surani
Journal:  Case Rep Gastrointest Med       Date:  2017-11-26

3.  Pediatric plexiform fibromyxoma: A PRISMA-compliant systematic literature review.

Authors:  Mitsuharu Fukazawa; Hiroshi Koga; Shoji Hiroshige; Toshifumi Matsumoto; Yuichi Nakazono; Yasuji Yoshikawa
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

Review 4.  An Update on Clinicopathological and Molecular Features of Plexiform Fibromyxoma.

Authors:  Hsuan-An Su; Hsu-Heng Yen; Chih-Jung Chen
Journal:  Can J Gastroenterol Hepatol       Date:  2019-07-07

Review 5.  Imaging findings of gastric plexiform fibromyxoma with a cystic change: A case report and review of literature.

Authors:  Min-Xia Yang; Zhen-Hua Zhao; Jian-Feng Yang; Bing Chen; Xun-Ze Shen; Jian-Guo Wei; Bo-Yin Wang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

Review 6.  Plexiform fibromyxoma: a clinicopathological and immunohistochemical analysis of two cases with a literature review.

Authors:  Shaofei Ma; Jing Wang; Zhanjun Lu; Chaoying Shi; Daohua Yang; Jun Lin
Journal:  J Int Med Res       Date:  2021-08       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.